A PATIENT OF CD4- CD8+ CHRONIC T-CELL LEUKEMIA ASSOCIATED WITH HYPERCALCEMIA

被引:6
|
作者
TAMURA, K
SAGAWA, K
KIMURA, N
SATO, H
KATAKAMI, H
IMADA, S
INOUE, M
机构
[1] FUKUOKA UNIV,DEPT INTERNAL MED,FUKUOKA 81401,JAPAN
[2] KYUSHU UNIV HOSP,CLIN LAB,FUKUOKA 812,JAPAN
[3] MIYAZAKI MED COLL,DEPT INTERNAL MED,KIYOTAKE,JAPAN
[4] KURUME UNIV,SCH MED,DEPT IMMUNOL,KURUME,FUKUOKA 830,JAPAN
关键词
CHRONIC T-CELL LEUKEMIA; CD8+; HYPERCALCEMIA; PTH-RELATED PEPTIDE;
D O I
10.1016/0145-2126(91)90143-H
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A patient with chronic T-cell leukemia characterized by a suppressor phenotype is reported. A 71-year-old woman presented with symptoms and signs of hypercalcemia. Peripheral blood specimen showed abnormal lymphoid cells with an oval to cleaved nucleus, rather condensed chromatin, occasional prominent nucleolus, and basophilic cytoplasms with vacuoles which seems to be a T-cell counterpart of B-cell chronic lymphocytic leukemia with mixed cell types. The phenotype of these cells was CD4-, CD8+, CD5+, CD6+ with poor expression of CD3, CD7, and CD25. Southern blot analysis of T-cell receptor beta-chain gene revealed one allele rearranged band. The serum antibodies were positive against human T-cell leukemia virus, type I-associated antigens, but monoclonal integration of proviral DNA was not detected in the leukemic cells suggesting that she was just a carrier of this virus. Interestingly, serum PTH-related peptide (PRP) was elevated. The combination therapy with vincristine and prednisolone for leukemia decreased not only the number of leukemic cells but also the serum PRP levels. The clinical course was aggressive. She only responded transiently to treatments, and died of renal failure due to uncontrollable hypercalcemia six weeks after admission.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 50 条
  • [1] CYTOTOXIC SUPPRESSOR (CD8+, CD4-) CUTANEOUS T-CELL LYMPHOMA WITH AGGRESSIVE COURSE
    URRUTIA, S
    PIRIS, MA
    ORRADRE, JL
    MARTINEZ, B
    CRUZ, MA
    GARCIAALMAGRO, D
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1990, 12 (06) : 603 - 606
  • [2] CD8+ T-cell prolymphocytic leukemia
    Nakajima, H
    Oki, M
    Ando, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) : 560 - 562
  • [3] A γ/δ T-cell Receptor Prolymphocytic Leukemia and CD4-/CD8- Double-negative Immunophenotype in a Pediatric Patient
    Moser, Asher M.
    Quider, Abed A.
    Groen, Jeremiah A.
    Shubinsky, George
    Kapelushnik, Joseph
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (04) : E218 - E219
  • [4] T-CELL PROLYMPHOCYTIC LEUKEMIA WITH AN UNUSUAL PHENOTYPE CD4+ CD8+
    KLUINNELEMANS, HC
    GMELIGMEYLING, FHJ
    KOOTTE, AMM
    DENOTTOLANDER, GJ
    TERMIJTELEN, A
    KLUIN, PM
    BEVERSTOCK, GC
    BRAND, A
    CANCER, 1987, 60 (04) : 794 - 803
  • [5] Differential Diagnosis of CD4-/CD8-γδ T-Cell Large Granular Lymphocytic Leukemia and Hepatosplenic T-Cell Lymphoma
    Chen, Yi-Hua
    Peterson, LoAnn
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (03) : 496 - 497
  • [6] Towards a cellular definition of CD8+ T-cell memory:: the role of CD4+ T-cell help in CD8+ T-cell responses
    Rocha, B
    Tanchot, C
    CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (03) : 259 - 263
  • [7] A CASE OF CD3+, CD4-, CD8-, WT31- ACUTE T-CELL LEUKEMIA
    SUNISLOE, LL
    SOAMBOONSRUP, P
    ANDREW, M
    NEAME, PB
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1989, 92 (01) : 115 - 119
  • [8] CD4-/CD8- Variant of T-Cell Large Granular Lymphocytic Leukemia or Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Dilemma
    Benjamini, Ohad
    Jain, Preetesh
    Konoplev, Sergej N.
    Yin, Cheng Cameron
    Abruzzo, Lynne
    Wotherspoon, Andrew C.
    Dearden, Claire
    Shpall, Elizabeth J.
    Estrov, Zeev
    Keating, Michael J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (05): : 610 - 613
  • [9] IMMATURE CD4- CD8+ MURINE THYMOCYTES
    SHORTMAN, K
    WILSON, A
    EGERTON, M
    PEARSE, M
    SCOLLAY, R
    CELLULAR IMMUNOLOGY, 1988, 113 (02) : 462 - 479
  • [10] T-CELL MALIGNANCY IN RICHTERS SYNDROME PRESENTING AS HYPER IGM - INDUCTION AND CHARACTERIZATION OF A NOVEL CD3+, CD4-, CD8+ T-CELL SUBSET FROM PHYTOHEMAGGLUTININ-STIMULATED PATIENTS CD3+, CD4+, CD8+ LEUKEMIC T-CELLS
    RAZIUDDIN, S
    ASSAF, HM
    TEKLU, B
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (03) : 469 - 474